In Vitro Analyses of Endothelial Cell Permeability

Methods in Molecular Biology

Volumn 763, Issue , 2011, Pages 281-290

  Monaghan Benson, Elizabeth ^a   Wittchen, Erika S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Barrier function; Endothelial cell; Endothelium; FITC dextran; Impedance sensing; Permeability; Transendothelial resistance

Indexed keywords

8 ((4 CHLOROPHENYL)THIO)CYCLIC 3',5' AMP; 8-((4-CHLOROPHENYL)THIO)CYCLIC-3',5'-AMP; CADHERIN; CYCLIC AMP; DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LEUKOCYTE ANTIGEN; NUCLEOTIDE; THROMBIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL JUNCTION; CYTOLOGY; DIFFUSION CHAMBER; DRUG EFFECT; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; IMPEDANCE; METABOLISM; METHODOLOGY; PERMEABILITY; POTENTIOMETRY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD; CADHERINS; CYCLIC AMP; DEXTRANS; DIFFUSION CHAMBERS, CULTURE; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM; FLUORESCEIN-5-ISOTHIOCYANATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; PERMEABILITY; POTENTIOMETRY; THIONUCLEOTIDES; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80054756702     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-191-8_19     Document Type: Chapter

References (13)

1. Lum H, and Malik AB (1994) The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy. Am J Physiol 3:L223–41.
2. Lee YC (2005) The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy. Curr Opin Investig Drugs 11:1124–30.
3. Mehta D, and Malik A (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 1:279–367.
4. Aghajanian A, Wittchen ES, Allingham MJ, Garrett TA, and Burridge K. (2008) Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration. J Thromb Haemost 6:1453–60.
5. Bogatcheva NV, Garcia JG, and Verin AD. (2002) Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 67:75–84.
6. Monaghan-Benson E, and Burridge K. (2009) The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284:25602–11.
7. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–5.
8. Atienza JM, Yu N, Kirstein SL, Xi B, Wang X, Xu X, and Abassi YA. (2006) Dynamic and label-free cell-based assays using the Real-Time Cell Electronic Sensing System. Assay and Drug Development Technologies 4: 597–607.
9. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, and Bos JL. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901–6.
10. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, and Mayadas TN. (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105:1950–5.
11. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, and Burridge K. (2005) Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem 280:11675–82.
12. Shasby DM, and Shasby SS. (1986) Effects of calcium on transendothelial albumin transfer and electrical resistance. J Appl Physiol 60:71–79.
13. Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, and Roos D. (1999) Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112:1915–23.